FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890980909> ?p ?o ?g. }

• W2890980909 endingPage "305" @default.
• W2890980909 startingPage "297" @default.
• W2890980909 abstract "To assess the effectiveness of low-dose-rate (LDR) brachytherapy in patients with localized prostate cancer and to compare the outcome with predictions from Kattan and Partin nomograms at 60 months after seed implantation.One thousand, one hundred and eighty-seven patients with localized prostate cancer at low-, intermediate-, or high-risk of progression received LDR brachytherapy using iodine-125 seeds with curative intent, applied as monotherapy or in combination with external beam radiation therapy (EBRT), and/or androgen deprivation therapy (ADT). At 60 months after seed implantation, data of 1,064 patients (1,058 alive + 6 who died of prostate cancer) were analyzed for biochemical progression-free survival (bPFS) based on prostate-specific antigen (PSA) levels using the Phoenix definition. Five-year bPFS probabilities were determined for various risk group classifications (d'Amico, Mt. Sinai, MSKCC/Seattle, NCCN). Outcomes were also compared to patient-individualized nomogram predictions of 5-year bPFS (Kattan 2002) and probability of organ-confined disease (Kattan 2002, Partin 2007).Overall, 93.3% (993/1,064) of the patients were free of biochemical progression within 5 years, while the average 5-year bPFS probability according to the Kattan nomogram was significantly lower (85%, p < 0.001). Outcomes were significantly better than Kattan nomogram predictions in the subgroup of patients with monotherapy as well as in patients additionally treated with EBRT. Comparison of the overall outcome with nomogram predictions for organ-confined disease (Kattan nomogram: 50%; Partin nomogram: 65%) revealed a significant probability of LDR brachytherapy to destroy periprostatic tumor spread (p < 0.001) in all risk group constellations, even in high-risk patients.The results indicate high effectiveness of LDR brachytherapy in all risk groups, significantly better than predicted with the Kattan nomogram in most subgroups. The significant superiority of LDR brachytherapy compared to nomogram predictions of organ-confined disease suggests that LDR brachytherapy effectively controls both intra- and periprostatic disease." @default.
• W2890980909 created "2018-09-27" @default.
• W2890980909 creator A5000188981 @default.
• W2890980909 creator A5005532061 @default.
• W2890980909 creator A5009476469 @default.
• W2890980909 creator A5016175506 @default.
• W2890980909 creator A5020189390 @default.
• W2890980909 creator A5022652563 @default.
• W2890980909 creator A5025437872 @default.
• W2890980909 creator A5027763328 @default.
• W2890980909 creator A5028938155 @default.
• W2890980909 creator A5029037056 @default.
• W2890980909 creator A5030419333 @default.
• W2890980909 creator A5032753991 @default.
• W2890980909 creator A5038692306 @default.
• W2890980909 creator A5051792525 @default.
• W2890980909 creator A5053729438 @default.
• W2890980909 creator A5053813993 @default.
• W2890980909 creator A5058407085 @default.
• W2890980909 creator A5067299658 @default.
• W2890980909 creator A5073700029 @default.
• W2890980909 creator A5081510826 @default.
• W2890980909 creator A5083103910 @default.
• W2890980909 date "2018-01-01" @default.
• W2890980909 modified "2023-10-01" @default.
• W2890980909 title "Five-year effectiveness of low-dose-rate brachytherapy: comparisons with nomogram predictions in patients with non-metastatic prostate cancer presenting significant control of intra- and periprostatic disease" @default.
• W2890980909 cites W1571792083 @default.
• W2890980909 cites W1649499304 @default.
• W2890980909 cites W1798554587 @default.
• W2890980909 cites W1926020851 @default.
• W2890980909 cites W1981103385 @default.
• W2890980909 cites W1987796424 @default.
• W2890980909 cites W1988456256 @default.
• W2890980909 cites W2008428383 @default.
• W2890980909 cites W2015114518 @default.
• W2890980909 cites W2040103703 @default.
• W2890980909 cites W2062313368 @default.
• W2890980909 cites W2066800897 @default.
• W2890980909 cites W2073237467 @default.
• W2890980909 cites W2082943541 @default.
• W2890980909 cites W2086930116 @default.
• W2890980909 cites W2093867637 @default.
• W2890980909 cites W2099832670 @default.
• W2890980909 cites W2108014935 @default.
• W2890980909 cites W2115318189 @default.
• W2890980909 cites W2117792530 @default.
• W2890980909 cites W2135435808 @default.
• W2890980909 cites W2139592406 @default.
• W2890980909 cites W2142470634 @default.
• W2890980909 cites W2146479031 @default.
• W2890980909 cites W2152891672 @default.
• W2890980909 cites W2156844161 @default.
• W2890980909 cites W2156997550 @default.
• W2890980909 cites W2163954169 @default.
• W2890980909 cites W2296568902 @default.
• W2890980909 cites W2511949746 @default.
• W2890980909 cites W2534892684 @default.
• W2890980909 cites W2553678345 @default.
• W2890980909 cites W2576505598 @default.
• W2890980909 cites W2584499267 @default.
• W2890980909 cites W2586277644 @default.
• W2890980909 cites W2597301728 @default.
• W2890980909 cites W2616221802 @default.
• W2890980909 cites W2619133091 @default.
• W2890980909 cites W2729996436 @default.
• W2890980909 cites W2732495552 @default.
• W2890980909 cites W2735010542 @default.
• W2890980909 cites W2761204422 @default.
• W2890980909 cites W2765172807 @default.
• W2890980909 cites W2785270133 @default.
• W2890980909 cites W2793885062 @default.
• W2890980909 cites W2809451573 @default.
• W2890980909 cites W2980837445 @default.
• W2890980909 cites W2606573700 @default.
• W2890980909 cites W2788943068 @default.
• W2890980909 doi "https://doi.org/10.5114/jcb.2018.77949" @default.
• W2890980909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6142645" @default.
• W2890980909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30237813" @default.
• W2890980909 hasPublicationYear "2018" @default.
• W2890980909 type Work @default.
• W2890980909 sameAs 2890980909 @default.
• W2890980909 citedByCount "9" @default.
• W2890980909 countsByYear W28909809092018 @default.
• W2890980909 countsByYear W28909809092019 @default.
• W2890980909 countsByYear W28909809092020 @default.
• W2890980909 countsByYear W28909809092021 @default.
• W2890980909 countsByYear W28909809092022 @default.
• W2890980909 crossrefType "journal-article" @default.
• W2890980909 hasAuthorship W2890980909A5000188981 @default.
• W2890980909 hasAuthorship W2890980909A5005532061 @default.
• W2890980909 hasAuthorship W2890980909A5009476469 @default.
• W2890980909 hasAuthorship W2890980909A5016175506 @default.
• W2890980909 hasAuthorship W2890980909A5020189390 @default.
• W2890980909 hasAuthorship W2890980909A5022652563 @default.
• W2890980909 hasAuthorship W2890980909A5025437872 @default.
• W2890980909 hasAuthorship W2890980909A5027763328 @default.
• W2890980909 hasAuthorship W2890980909A5028938155 @default.
• W2890980909 hasAuthorship W2890980909A5029037056 @default.

• next